Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis

Subclinical gut inflammation occurring in patients affected by spondyloarthritis (SpA) is correlated with the severity of spine inflammation. Several evidences indicate that dysbiosis occurs in SpA, and that may modulate intestinal permeability and intestinal immune responses. The presence of intest...

Full description

Bibliographic Details
Main Authors: Aroldo Rizzo, Giuliana Guggino, Angelo Ferrante, Francesco Ciccia
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2018.00063/full
_version_ 1818858559757090816
author Aroldo Rizzo
Giuliana Guggino
Angelo Ferrante
Francesco Ciccia
author_facet Aroldo Rizzo
Giuliana Guggino
Angelo Ferrante
Francesco Ciccia
author_sort Aroldo Rizzo
collection DOAJ
description Subclinical gut inflammation occurring in patients affected by spondyloarthritis (SpA) is correlated with the severity of spine inflammation. Several evidences indicate that dysbiosis occurs in SpA, and that may modulate intestinal permeability and intestinal immune responses. The presence of intestinal dysbiosis is accompanied in SpA patients with the presence of zonulin-dependent alterations of gut-epithelial and gut-vascular barriers. The leakage of epithelial and endothelial surface layers is followed by the translocation of bacterial products, such as lipopolysaccharide and intestinal fatty acid binding protein, in the systemic circulation. These bacterial products may downregulate the expression of CD14 on circulating monocytes leading to an “anergic” phenotype. In the gut, IL-23 may induce the expansion of innate immune cells such as mucosal-associated invariant T cells, γδ T cells, and innate lymphoid cells of group 3 that through the interaction with MAdCAM1 may recirculate form the gut to the sites of SpA active inflammation. On the basis of these findings, gut inflammation observed in SpA patient seems to be not only an epiphenomenon of the on going systemic inflammatory process but may also represent the base camp in which inflammatory cells are activated and from whom they shuttle.
first_indexed 2024-12-19T08:58:13Z
format Article
id doaj.art-b9b364d4066a4a61ac5321ff44fee0a3
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-19T08:58:13Z
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-b9b364d4066a4a61ac5321ff44fee0a32022-12-21T20:28:33ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-05-01510.3389/fmed.2018.00063323617Role of Subclinical Gut Inflammation in the Pathogenesis of SpondyloarthritisAroldo Rizzo0Giuliana Guggino1Angelo Ferrante2Francesco Ciccia3Dipartimento Biomedico di Medicina Interna e Specialistica, Università degli studi di Palermo, Palermo, ItalyUnità Operativa di Anatomia Patologica, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, ItalyUnità Operativa di Anatomia Patologica, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, ItalyUnità Operativa di Anatomia Patologica, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, ItalySubclinical gut inflammation occurring in patients affected by spondyloarthritis (SpA) is correlated with the severity of spine inflammation. Several evidences indicate that dysbiosis occurs in SpA, and that may modulate intestinal permeability and intestinal immune responses. The presence of intestinal dysbiosis is accompanied in SpA patients with the presence of zonulin-dependent alterations of gut-epithelial and gut-vascular barriers. The leakage of epithelial and endothelial surface layers is followed by the translocation of bacterial products, such as lipopolysaccharide and intestinal fatty acid binding protein, in the systemic circulation. These bacterial products may downregulate the expression of CD14 on circulating monocytes leading to an “anergic” phenotype. In the gut, IL-23 may induce the expansion of innate immune cells such as mucosal-associated invariant T cells, γδ T cells, and innate lymphoid cells of group 3 that through the interaction with MAdCAM1 may recirculate form the gut to the sites of SpA active inflammation. On the basis of these findings, gut inflammation observed in SpA patient seems to be not only an epiphenomenon of the on going systemic inflammatory process but may also represent the base camp in which inflammatory cells are activated and from whom they shuttle.http://journal.frontiersin.org/article/10.3389/fmed.2018.00063/fullspondylitisgut microbiomeinflammation mediatorsinnate immune responseenthesitis-related arthritis
spellingShingle Aroldo Rizzo
Giuliana Guggino
Angelo Ferrante
Francesco Ciccia
Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
Frontiers in Medicine
spondylitis
gut microbiome
inflammation mediators
innate immune response
enthesitis-related arthritis
title Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
title_full Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
title_fullStr Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
title_full_unstemmed Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
title_short Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis
title_sort role of subclinical gut inflammation in the pathogenesis of spondyloarthritis
topic spondylitis
gut microbiome
inflammation mediators
innate immune response
enthesitis-related arthritis
url http://journal.frontiersin.org/article/10.3389/fmed.2018.00063/full
work_keys_str_mv AT aroldorizzo roleofsubclinicalgutinflammationinthepathogenesisofspondyloarthritis
AT giulianaguggino roleofsubclinicalgutinflammationinthepathogenesisofspondyloarthritis
AT angeloferrante roleofsubclinicalgutinflammationinthepathogenesisofspondyloarthritis
AT francescociccia roleofsubclinicalgutinflammationinthepathogenesisofspondyloarthritis